Rani Therapeutics: Funding, Investors & Team (Sep 2026)
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs, the vast majority of which must be injected. We have developed the RaniPill™ technology to replace subcutaneous or IV injections of biologics with an oral pill. The RaniPill™ capsule is designed to deliver an injection to the intestinal wall, where there are no sharp pain receptors, and has achieved bioavailability similar to subcutaneous injections. We believe oral versions of biologics will have the potential to transform medicine and improve outcomes for the millions of patients who currently rely on chronic self-injections.
Rani Therapeutics has raised $55.0M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Jul 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rani Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Rani Therapeutics Funding Rounds
Rani Therapeutics raised $45.0M in a Post-IPO Debt announced in Aug 2022.
1.9 years later, an undisclosed round of $10.0M was announced in Jul 2024.
Rani Therapeutics Founders and Leadership Team
Contact details for the Rani Therapeutics team: 2 of 2 have an email address on file.
Start 14-day free trial →Rani Therapeutics Funding Compared to Other Biotechnology Startups
Rani Therapeutics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rani Therapeutics in Biotechnology and San Jose
Companies Similar to Rani Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Rani Therapeutics Funding FAQs
What does Rani Therapeutics do?
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs, the vast majority of which must be injected. We have developed the RaniPill™ technology to replace subcutaneous or IV injections of biologics with an oral pill. The RaniPill™ capsule is designed to deliver an injection to the intestinal wall, where there are no sharp pain receptors, and has achieved bioavailability similar to subcutaneous injections. We believe oral versions of biologics will have the potential to transform medicine and improve outcomes for the millions of patients who currently rely on chronic self-injections.
How much funding has Rani Therapeutics raised?
Rani Therapeutics has raised $55.0M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Jul 2024.
When did Rani Therapeutics last raise funding?
Rani Therapeutics' most recent funding round on record is an undisclosed round of $10.0M, announced in Jul 2024.
Who founded Rani Therapeutics?
FundedIQ lists Mir Imran (Founder) at Rani Therapeutics.
Who is the CEO of Rani Therapeutics?
Talat Imran is listed as CEO at Rani Therapeutics.
Where is Rani Therapeutics headquartered?
Rani Therapeutics is based in San Jose, California, United States.
How many employees does Rani Therapeutics have?
Rani Therapeutics is in the 101-250 employee band.
How does Rani Therapeutics' funding compare to other Biotechnology startups?
Rani Therapeutics' latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Rani Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rani Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.